Physician profile
Maritess Thomas
NPI 1013461425
$1,869.47
in general payments reported to CMS, 2019-2025
23 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $841 · 2022: $574 · 2023: $13.81 · 2024: $204 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.00 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $279.15 | 2022-2025 | |
| Novo Nordisk INC | $277.35 | 2021-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $134.62 | 2021-2024 | Airsupra |
| Lilly USA, LLC | $119.76 | 2021-2025 | Mounjaro |
| Otsuka America Pharmaceutical, INC. | $118.92 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.55 | 2021-2025 | Jardiance, Synjardy |
| Sanofi-Aventis U.S. LLC | $75.58 | 2022 | |
| Pfizer INC. | $72.75 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $56.64 | 2021 | |
| Exact Sciences Corporation | $50.77 | 2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $43.14 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.03 | 2021 | |
| Abbott Laboratories | $37.36 | 2022 | |
| Paratek Pharmaceuticals, INC. | $34.66 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Global Blood Therapeutics, INC. | $23.51 | 2022 | |
| Glaxosmithkline, LLC. | $22.00 | 2022 | |
| Vanda Pharmaceuticals INC. | $19.74 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.36 | 2021 | |
| Eisai INC. | $13.83 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.82 | 2025 | Zoryve |
| Horizon Therapeutics Plc | $12.77 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maritess Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.